Related Experiment Video
Updated: May 31, 2026
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
Published on: November 12, 2019
xCELLigence™ RTCA system in cancer biology: innovations in real-time functional profiling
Charlene Andraos1,2, Jitcy Saji Joseph1,3, Wells Utembe1,4
1Department of Toxicology and Biochemistry, A division of National Health Laboratory Services, National Institute for Occupational Health, Johannesburg, South Africa.
The xCELLigence™ Real-Time Cell Analysis (RTCA) system provides crucial kinetic data for cancer research, overcoming limitations of traditional assays. This label-free technology offers continuous monitoring of cellular behavior for improved understanding of cancer pathogenesis and drug development.
Area of Science:
- Oncology
- Biotechnology
- Cell Biology
Background:
- Cancer pathogenesis involves complex molecular mechanisms poorly understood by static measurements.
- Traditional assays like MTT and transwell migration fail to capture the dynamic 3D tumor microenvironment kinetics.
- High-resolution kinetic data on cancer cell invasion, proliferation, migration, and cytotoxicity are essential for effective cancer immunotherapeutics.
Purpose of the Study:
- To review the advancements and applications of the xCELLigence™ Real-Time Cell Analysis (RTCA) system in cancer research.
- To emphasize how impedance-derived kinetic signatures enhance mechanistic understanding of tumor cell behavior.
- To discuss the translational relevance of RTCA for drug development and precision oncology.
Main Methods:
- Review of recent literature on xCELLigence™ RTCA applications in cancer research since 2020.
- Analysis of impedance-derived kinetic signatures for mechanistic insights into tumor cell behavior.
- Critical discussion of quantitative metrics from real-time impedance measurements and comparison with conventional assays.
Main Results:
- RTCA enables non-invasive, label-free, continuous monitoring of cellular behavior via impedance-based technology.
- RTCA applications have expanded significantly in areas like kinase inhibition, immunotherapy, and 3D tumor models.
- Impedance signatures provide enhanced mechanistic understanding of tumor cell dynamics, surpassing static measurements.
Conclusions:
- The xCELLigence™ RTCA system is a major advancement for cancer research, offering high-resolution kinetic data.
- RTCA enhances mechanistic understanding and has translational relevance for drug development and precision oncology.
- Further development can consolidate RTCA as a predictive and integrative platform in preclinical cancer research.
